Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions James Thorne
Petmed Express IncPETSCOMMENTJun 16, 2016
James ThorneUnknown
$18.19
Stock price when the opinion was issued
$1.85
As of Jun 12, 2026. Market Open.
specialty stores
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium contentPAST TOP PICK
(A Top Pick May 06/21, Down 10.4%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with PETS has triggered its stop at $27.50. We recommend covering the balance of the position at this time. When combined with the previous recommendation to cover half the position, this results in a net investment gain over 11%.
specialty stores
Premium contentPAST TOP PICK
(A Top Pick May 06/21, Up 33.5%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with PETS has achieved its $41 objective. To be disciplined, we recommend covering 50% at this level and trailing up the stop from $22.50 to $27.50. It triggered, this would result in a combined return on investment over 11%.
specialty stores
Premium contentTOP PICK
Stockchase Research Editor: Michael O'Reilly The company operates as a pet pharmacy. The industry has done well during the pandemic. The company trades at 20x earnings, compared to peers at 36x. Over 90% of the shares are held by institutions, making it have good staying power. It pays a good dividend, backed by a payout ratio of 75% of cash flow -- sustainable. We would buy this with a stop loss at $22.50, looking to achieve $41 -- upside potential over 32%. Yield 3.69% (Analysts’ price target is $41.00)
specialty stores
An online-server where you get your pet foods and pet medicines delivered to you. Has a decent dividend, but doesn’t really have any growth. Doesn’t have a defendable moat so that there is no competitive advantage. Thinks it is going to be okay here, but at the same time wouldn’t be surprised to see others replicate the model. Dividend yield of 4.2%.